Verdence Capital Advisors LLC Pfizer Inc Transaction History

Verdence Capital Advisors LLC

$1.23 Billion
Q3 2024

A detailed history of Verdence Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 128,195 shares of PFE stock, worth $3.22 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

128,195

Previous 128,735 0.42%

Holding current value

$3.22 Million

Previous $3.6 Million 2.97%

% of portfolio

0.3%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $14,958 - $16,950	-540 Reduced 0.42%	128,195 $3.71 Million
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $89,193 - $104,517	-3,531 Reduced 2.67%	128,735 $3.6 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $333,618 - $383,100	12,886 Added 10.79%	132,266 $3.67 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $411,181 - $534,079	-15,736 Reduced 11.65%	119,380 $3.44 Million
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $79,198 - $92,574	-2,468 Reduced 1.79%	135,116 $4.48 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $45,402 - $52,530	1,257 Added 0.92%	137,584 $5.05 Million
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $120,494 - $156,865	3,059 Added 2.3%	136,327 $5.56 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $305,276 - $398,504	-7,312 Reduced 5.2%	133,268 $0
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $75,179 - $91,775	1,718 Added 1.24%	140,580 $6.15 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $202,917 - $240,596	-4,361 Reduced 3.04%	138,862 $7.28 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $1.06 Million - $1.31 Million	23,126 Added 19.26%	143,223 $7.42 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $222,590 - $329,953	-5,387 Reduced 4.29%	120,097 $7.09 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $356,350 - $457,763	-9,079 Reduced 6.75%	125,484 $5.4 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $2.47 Million - $2.8 Million	68,883 Added 104.88%	134,563 $5.27 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $169,760 - $191,456	-5,069 Reduced 7.16%	65,680 $2.38 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $143,954 - $183,050	-4,301 Reduced 5.73%	70,749 $2.6 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $86,677 - $101,692	-2,730 Reduced 3.51%	75,050 $2.75 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $2.67 Million - $3.24 Million	-88,546 Reduced 53.24%	77,780 $2.54 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $1.34 Million - $1.92 Million	49,747 Added 42.67%	166,326 $5.43 Million
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $494,392 - $561,072	-15,018 Reduced 11.41%	116,579 $4.57 Million
Q3 2019 Mar 06, 2020	BUY	$32.49 - $42.13 $457,004 - $592,600	14,066 Added 11.97%	131,597 $4.73 Million
Q2 2019 Mar 02, 2020	SELL	$36.98 - $41.52 $576,370 - $647,130	-15,586 Reduced 11.71%	117,531 $5.09 Million
Q1 2019 Mar 02, 2020	SELL	$37.5 - $41.2 $4.1 Million - $4.51 Million	-109,444 Reduced 45.12%	133,117 $5.65 Million
Q4 2018 Feb 25, 2020	SELL	$38.47 - $43.86 $1.1 Million - $1.25 Million	-28,521 Reduced 10.52%	242,561 $10.6 Million
Q3 2018 Feb 25, 2020	SELL	$34.47 - $41.81 $746,895 - $905,939	-21,668 Reduced 7.4%	271,082 $11.9 Million
Q2 2018 Feb 11, 2020	SELL	$32.98 - $35.16 $152,037 - $162,087	-4,610 Reduced 1.55%	292,750 $10.6 Million
Q1 2018 Jan 30, 2020	SELL	$31.91 - $37.02 $47,482 - $55,085	-1,488 Reduced 0.5%	297,360 $10.6 Million
Q4 2017 Jan 30, 2020	BUY	$33.26 - $35.29 $9.94 Million - $10.5 Million	298,848	298,848 $10.8 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Pfizer Inc Transaction History